[Anaphylactic shock associated with a central venous catheter impregnated with chlorhexidine and silver sulfadiazine]. 1998

E Terazawa, and K Nagase, and T Masue, and Y Niwa, and I Fukao, and H Shimonaka, and T Yokoi, and N Kondoh, and S Dohi
Department of Anesthesiology, Gifu Prefectural Hospital.

A 28 year-old male patient developed anaphylactic shock on separate occasions, possibly due to the contact with a central venous catheter impregnated with chlorhexidine and silver sulfadiazine. He was successfully resuscitated. On the second operation, blood basophils disappeared and plasma histamine level increased extremely up to 80 ng.ml-1 soon after anaphylactic shock. One year after the first shock, he did not develop anaphylactic shock following the insertion of a central venous catheter without the impregnation. Pin prick test and scratch test showed positive reactions only to chlorhexidine. Latex-specific anti-IgE antibody was not detected. Therefore, chlorhexidine was confirmed as the causative agent of anaphylactic shock. Because chlorhexidine is extensively used as an antiseptic drug in emergency rooms and intensive care units, we should be aware of the possibility of chlorhexidine induced anaphylactic reactions.

UI MeSH Term Description Entries
D008297 Male Males
D002405 Catheterization, Central Venous Placement of an intravenous CATHETER in the subclavian, jugular, or other central vein. Central Venous Catheterization,Venous Catheterization, Central,Catheterization, Central,Central Catheterization,Catheterizations, Central,Catheterizations, Central Venous,Central Catheterizations,Central Venous Catheterizations,Venous Catheterizations, Central
D002710 Chlorhexidine A disinfectant and topical anti-infective agent used also as mouthwash to prevent oral plaque. Chlorhexidine Acetate,Chlorhexidine Hydrochloride,MK-412A,Novalsan,Sebidin A,Tubulicid,Acetate, Chlorhexidine,Hydrochloride, Chlorhexidine,MK 412A,MK412A
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000707 Anaphylaxis An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death. Anaphylactic Reaction,Anaphylactoid Reaction,Anaphylactoid Shock,Shock, Anaphylactic,Anaphylactic Reactions,Anaphylactic Shock,Anaphylactoid Reactions,Reaction, Anaphylactic,Reaction, Anaphylactoid,Shock, Anaphylactoid
D000891 Anti-Infective Agents, Local Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. Anti-Infective Agents, Topical,Antiseptic,Antiseptics,Microbicides, Local,Microbicides, Topical,Antiinfective Agents, Local,Antiinfective Agents, Topical,Local Anti-Infective Agents,Local Antiinfective Agents,Topical Anti-Infective Agents,Topical Antiinfective Agents,Agents, Local Anti-Infective,Agents, Local Antiinfective,Agents, Topical Anti-Infective,Agents, Topical Antiinfective,Anti Infective Agents, Local,Anti Infective Agents, Topical,Local Anti Infective Agents,Local Microbicides,Topical Anti Infective Agents,Topical Microbicides
D012837 Silver Sulfadiazine Antibacterial used topically in burn therapy. Brandiazin,Dermazin,Flamazine,Flammazine,SSD,SSD AF,Sicazine,Silvadene,Silvederma,Sulfafdiazine, Silver,Sulfargen,Thermazene,Silver Sulfafdiazine,Sulfadiazine, Silver

Related Publications

E Terazawa, and K Nagase, and T Masue, and Y Niwa, and I Fukao, and H Shimonaka, and T Yokoi, and N Kondoh, and S Dohi
March 1996, Journal of clinical microbiology,
E Terazawa, and K Nagase, and T Masue, and Y Niwa, and I Fukao, and H Shimonaka, and T Yokoi, and N Kondoh, and S Dohi
October 1996, Journal of clinical microbiology,
E Terazawa, and K Nagase, and T Masue, and Y Niwa, and I Fukao, and H Shimonaka, and T Yokoi, and N Kondoh, and S Dohi
March 2014, American journal of infection control,
E Terazawa, and K Nagase, and T Masue, and Y Niwa, and I Fukao, and H Shimonaka, and T Yokoi, and N Kondoh, and S Dohi
October 2015, Journal of the American College of Surgeons,
E Terazawa, and K Nagase, and T Masue, and Y Niwa, and I Fukao, and H Shimonaka, and T Yokoi, and N Kondoh, and S Dohi
October 2005, Annals of internal medicine,
E Terazawa, and K Nagase, and T Masue, and Y Niwa, and I Fukao, and H Shimonaka, and T Yokoi, and N Kondoh, and S Dohi
December 2004, American journal of infection control,
E Terazawa, and K Nagase, and T Masue, and Y Niwa, and I Fukao, and H Shimonaka, and T Yokoi, and N Kondoh, and S Dohi
April 2005, Annals of hematology,
E Terazawa, and K Nagase, and T Masue, and Y Niwa, and I Fukao, and H Shimonaka, and T Yokoi, and N Kondoh, and S Dohi
December 2003, Anaesthesia and intensive care,
E Terazawa, and K Nagase, and T Masue, and Y Niwa, and I Fukao, and H Shimonaka, and T Yokoi, and N Kondoh, and S Dohi
July 2015, American journal of infection control,
E Terazawa, and K Nagase, and T Masue, and Y Niwa, and I Fukao, and H Shimonaka, and T Yokoi, and N Kondoh, and S Dohi
April 2012, The new microbiologica,
Copied contents to your clipboard!